ALBANESI, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 1.966
EU - Europa 920
AS - Asia 731
SA - Sud America 178
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 46
Totale 3.930
Nazione #
US - Stati Uniti d'America 1.903
SG - Singapore 277
IT - Italia 271
DE - Germania 217
CN - Cina 182
RU - Federazione Russa 136
BR - Brasile 133
SE - Svezia 96
GB - Regno Unito 76
HK - Hong Kong 68
VN - Vietnam 58
FR - Francia 43
BD - Bangladesh 32
IN - India 30
CA - Canada 25
FI - Finlandia 20
CI - Costa d'Avorio 19
TR - Turchia 15
AR - Argentina 12
EC - Ecuador 12
ES - Italia 12
PL - Polonia 12
IQ - Iraq 11
PK - Pakistan 11
CO - Colombia 10
BE - Belgio 9
ID - Indonesia 9
MX - Messico 9
ZA - Sudafrica 9
CR - Costa Rica 7
MA - Marocco 7
SA - Arabia Saudita 7
JO - Giordania 6
NL - Olanda 6
SV - El Salvador 6
JP - Giappone 5
LT - Lituania 5
CZ - Repubblica Ceca 4
PH - Filippine 4
CL - Cile 3
GT - Guatemala 3
HN - Honduras 3
IE - Irlanda 3
PA - Panama 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MW - Malawi 1
MY - Malesia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 3.843
Città #
Ashburn 284
Singapore 164
Chandler 154
Fairfield 151
San Jose 121
Houston 120
Nyköping 86
Hong Kong 68
Seattle 65
Beijing 60
New York 60
Woodbridge 59
Milan 57
Dallas 53
Wilmington 48
Ann Arbor 45
Cambridge 44
Council Bluffs 34
Munich 30
Los Angeles 28
Dearborn 22
Brooklyn 21
Lawrence 20
Abidjan 19
Bari 19
Roxbury 19
Ho Chi Minh City 18
Lauterbourg 17
Santa Clara 17
Rome 15
Helsinki 14
Nanjing 14
Des Moines 13
Columbus 12
São Paulo 12
Buffalo 11
Figino 11
Hanoi 11
Boardman 10
Denver 10
Boston 9
Brussels 9
San Diego 9
San Francisco 9
Frankfurt am Main 8
Redwood City 8
Inglewood 7
Shenyang 7
Amman 6
Baghdad 6
Changsha 6
Chicago 6
Falkenstein 6
Orem 6
Quito 6
San José 6
The Dalles 6
Warsaw 6
Atlanta 5
Chennai 5
Dong Ket 5
Jakarta 5
Jiaxing 5
London 5
Martina Franca 5
Modugno 5
North Bergen 5
Rio de Janeiro 5
San Salvador 5
Shenzhen 5
Turku 5
Basingstoke 4
Belo Horizonte 4
Caxias do Sul 4
Cincinnati 4
Fortaleza 4
Jeddah 4
Johannesburg 4
Lahore 4
Montreal 4
Naples 4
Paris 4
Porto Alegre 4
Pune 4
Queens 4
Shanghai 4
Turin 4
Washington 4
Amsterdam 3
Ancona 3
Ankara 3
Brasília 3
Calgary 3
Casablanca 3
Chieti 3
Cutrofiano 3
Edinburgh 3
Faisalabad 3
Genoa 3
Guangzhou 3
Totale 2.331
Nome #
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 267
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 257
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione. 219
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 206
Is immunotherapy with fungal vaccines effective? 200
Wasp immunotherapy induced long-term and IgG4-independent protection 180
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 180
Cost-effectiveness of grass pollen allergen immunotherapy in adults 164
Immunological characterization of onion (Allium cepa) allergy 156
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità. 148
Test di proliferazione linfocitaria nella diagnosi delle reazioni ritardate a farmaci 142
Desensitization in Iron Product Allergy 138
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 136
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 135
Delayed allergy to acyclovir revealed by lymphocyte proliferation test 121
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management 115
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study 114
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 114
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 113
Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review 107
null 101
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 98
Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting 96
Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: A case report 93
A challenge in emergency department: a case report of oxaliplatin-induced Kounis syndrome 78
null 72
null 68
null 64
null 48
Totale 3.930
Categoria #
all - tutte 15.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022151 0 0 0 0 3 20 5 14 8 18 28 55
2022/2023362 28 75 32 20 36 47 7 31 70 2 8 6
2023/2024173 7 22 11 11 9 63 21 8 1 2 4 14
2024/2025529 32 3 35 22 21 59 49 59 17 29 79 124
2025/20261.266 183 83 87 121 168 66 112 31 143 124 26 122
2026/2027315 38 39 96 129 13 0 0 0 0 0 0 0
Totale 3.930